72.19.Z - Other research and experimental development on natural sciences and engineering
20.59.Z - Manufacture of other chemical products not elsewhere classified
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.20.Z - Research and experimental development on social sciences and humanities
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
82.99.Z - Other business support service activities not elsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 33,8 | 24,1 | -28,6 | |
EBITDA | ||||
Short time liabilities | ||||
Income tax | 0 | 2,2 | -∞ | |
Equity capital | 155,6 | 237,2 | 259,1 | 9,2 |
Operating profit (EBIT) | ||||
Assets | 275,2 | 242,1 | 264,6 | 9,3 |
Net profit (loss) | -5,6 | 33,8 | 21,9 | -35 |
Cash | ||||
Net income from sale | ||||
Liabilities and provisions for liabilities | 38,4 | 4,9 | 5,5 | 12,5 |
Working assets | 80,1 | 62,6 | 49,6 | -20,7 |
Basic operational activity income | 0,9 | 42,4 | 88,7 | 109,2 |
Depreciation | ||||
% | % | % | p.p. | |
Profitability of capital | -3,6 | 14,2 | 8,5 | -5,7 |
Equity capital to total assets | 56,6 | 98 | 97,9 | -0,1 |
Gross profit margin | 79,6 | 27,2 | -52,4 | |
EBITDA Margin | ||||
Days | Days | Days | Days | |
Short term commitment turnover cycle | ||||
Current financial liquidity indicator | ||||
Net dept to EBITDA |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane